Recent News

• 08.29.2025 - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.29.2025 - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.11.2025 - Q2 2025 Xenon Pharmaceuticals Inc. Earnings Conference Call
• 08.11.2025 - Xenon Reports Second Quarter 2025 Financial Results & Business Update
• 08.11.2025 - Xenon Reports Second Quarter 2025 Financial Results & Business Update
• 08.04.2025 - Xenon to Report Q2 2025 Financial Results on August 11, 2025
• 08.04.2025 - Xenon to Report Q2 2025 Financial Results on August 11, 2025
• 08.01.2025 - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.01.2025 - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 06.27.2025 - Xenon Joins the Russell 3000® and Russell 2000® Indexes

Recent Filings

• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 8-K Current report
• 08.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.03.2025 - 8-K Current report